127 related articles for article (PubMed ID: 11107131)
1. Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.
Goto H; Keshelava N; Matthay KK; Lukens JN; Gerbing RB; Stram DO; Seeger RC; Reynolds CP
Med Pediatr Oncol; 2000 Dec; 35(6):619-22. PubMed ID: 11107131
[TBL] [Abstract][Full Text] [Related]
2. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD
J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006
[TBL] [Abstract][Full Text] [Related]
3. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells.
Haber M; Bordow SB; Gilbert J; Madafiglio J; Kavallaris M; Marshall GM; Mechetner EB; Fruehauf JP; Tee L; Cohn SL; Salwen H; Schmidt ML; Norris MD
Oncogene; 1999 Apr; 18(17):2777-82. PubMed ID: 10348353
[TBL] [Abstract][Full Text] [Related]
5. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract][Full Text] [Related]
6. ABC transporters and neuroblastoma.
Yu DM; Huynh T; Truong AM; Haber M; Norris MD
Adv Cancer Res; 2015; 125():139-70. PubMed ID: 25640269
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.
Norris MD; Smith J; Tanabe K; Tobin P; Flemming C; Scheffer GL; Wielinga P; Cohn SL; London WB; Marshall GM; Allen JD; Haber M
Mol Cancer Ther; 2005 Apr; 4(4):547-53. PubMed ID: 15827327
[TBL] [Abstract][Full Text] [Related]
8. Role of chemotherapy resistance genes in outcome of neuroblastoma.
de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
[TBL] [Abstract][Full Text] [Related]
9. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
11. Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
Munoz M; Henderson M; Haber M; Norris M
IUBMB Life; 2007 Dec; 59(12):752-7. PubMed ID: 18085475
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin.
Norris MD; Madafiglio J; Gilbert J; Marshall GM; Haber M
Med Pediatr Oncol; 2001 Jan; 36(1):177-80. PubMed ID: 11464877
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
14. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.
Manohar CF; Bray JA; Salwen HR; Madafiglio J; Cheng A; Flemming C; Marshall GM; Norris MD; Haber M; Cohn SL
Oncogene; 2004 Jan; 23(3):753-62. PubMed ID: 14737110
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.
Spiegl-Kreinecker S; Buchroithner J; Elbling L; Steiner E; Wurm G; Bodenteich A; Fischer J; Micksche M; Berger W
J Neurooncol; 2002 Mar; 57(1):27-36. PubMed ID: 12125964
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
17. Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy.
Larbcharoensub N; Leopairat J; Sirachainan E; Narkwong L; Bhongmakapat T; Rasmeepaisarn K; Janvilisri T
Hum Pathol; 2008 Jun; 39(6):837-45. PubMed ID: 18400250
[TBL] [Abstract][Full Text] [Related]
18. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
19. Expression of the multidrug resistance, MDR1, gene in neuroblastomas.
Goldstein LJ; Fojo AT; Ueda K; Crist W; Green A; Brodeur G; Pastan I; Gottesman MM
J Clin Oncol; 1990 Jan; 8(1):128-36. PubMed ID: 2295903
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of MDR1 gene expression in primary untreated neuroblastoma.
Haber M; Bordow SB; Haber PS; Marshall GM; Stewart BW; Norris MD
Eur J Cancer; 1997 Oct; 33(12):2031-6. PubMed ID: 9516848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
